• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
    • Why Should You Support SAGES?
    • SAGES Swag
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Annual Meeting
      • 2027 Scientific Session Call for Abstracts
      • 2027 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • SAGES Lead Up Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • Innovative Surgical Trends
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Advanced Laparoscopy and Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
    • Foregut Video Atlas
  • Opportunities
    • Join the SAGES Patient Partner Network (PPN)
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs
  • Learning Hub
You are here: Home / Abstracts / Prospective Randomized Clinical Trial Comparing Laparoscopic Cholecystectomy and Hybrid Natural Orifice Translumenal Endoscopic Surgery (notes) (nct00835250)

Prospective Randomized Clinical Trial Comparing Laparoscopic Cholecystectomy and Hybrid Natural Orifice Translumenal Endoscopic Surgery (notes) (nct00835250)

José F Noguera, PhD MD, Angel Cuadrado, PhD MD, Juan C García, MD, Rafael Morales, MD, José M Olea, MD. Hospital Son Llàtzer, IUNICS, IDMQ

 

PURPOSE.

The purpose of the study is to determine the feasibility of cholecystectomy made by a transvaginal approach with a NOTES procedure (natural orifice translumenal endoscopic surgery).

DESIGN.

Study Type: Interventional
Study Design:
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Outcome Measures:
Parietal complications after surgery (infection and hernia) [ Time Frame: One year ].

 

Secondary Outcome Measures:
Surgical pain. General complications. Patient’s preferences. [ Time Frame: One year ]

 

METHODS.

Prospective randomized clinical series of 60 female patients with gallstones that underwent endoscopic surgery, 20 of them operated with conventional laparoscopic approach, 20 by transumbilical endoscopic approach and 20 of them by transvaginal endoscopic approach. Variables as surgical wound infection, urinary tract infection, evisceration, hernia, mortality and other complications will be analyzed.

Eligibility
Ages Eligible for Study: 18 Years to 65 Years
Genders Eligible for Study: Female
Accepts Healthy Volunteers: No

Inclusion Criteria:age over 18 and under 65
symptomatic cholelithiasis with an indication for performing laparoscopic surgery
absence of any gynecological condition that could complicate the procedure (pelvic inflammatory disease or endometriosis)
perforated hymen
agreement on the patient’s part not to use the vagina for two weeks after the surgery
signed specific informed consent upon providing specific information about the new surgical approach.

Exclusion Criteria:age under 18 or over 65
unperforated hymen
presence of illness or condition with an increased risk of pelvic damage with transvaginal approach.

RESULTS.

Surgical Complications. There were no significant differences.

Conversion to laparoscopic or open surgery. 1case in transumbilical group, converted to laparoscopy by difficulty in handling the endoscope. No significant differences.

Enlargement of the entry port. In laparoscopic group 66.7% needed an enlargement, 45% in transumbilical group, while in transvaginal group expansion was not required in any case. Enlargement has not been associated with wound complications.

Postoperative pain. There were no differences in postoperative pain quantified by VAS scores. (Treatment: Dipyrone 1 g ev x 6h).

Dyspareunia. The incidence of dyspareunia was nil (one year follow-up)

Hospital stay. There were no differences between groups. Hospital stay was 24 hours for 58 patients, two patients required two days. The protocol required one-day-stay.

Cost of the procedure. Cost was higher for groups that used the endoscope, because of the cost of the flexible endoscope. From case 30 onwards, the cost is the same for the procedures.

Surgical time. Significant differences between laparoscopy (47,04 minutes) and the other two techniques (transumbilical 59,80 and transvaginal 64,85). (Mann-Whitney test, p <0.001).

CONCLUSIONS.

Transvaginal approach with flexible endoscope is not inferior in efficacy and safety to conventional laparoscopy.
Transumbilical approach with the flexible endoscope is as effective and safe as transvaginal one and it’s is promising for the future (Flexible Single Incision Surgery).


Session Number: SS06 – NOTES
Program Number: S033

Related



Hours & Info

15821 Ventura Blvd Ste 400
Encino, CA 91436

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2026 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

Refine Search